The stock's rise snapped a four-day losing streak.

On Wednesday, Hologic Inc (HOLX) stock saw a decline, ending the day at $68.75 which represents a decrease of $-1.45 or -2.07% from the prior close of $70.2. The stock opened at $69.97 and touched a ...

Enough evidence for jury to consider failure to warn claim Case is one of nearly two dozen Hologic faces over BioZorb Hologic Inc. can’t shake a woman’s suit alleging the medical device manufacturer ...

Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.

Shares of Hologic Inc. HOLX slid 2.07% to $68.75 Wednesday, on what proved to be an all-around great trading session for the ...

With a market cap of $15.9 billion, Marlborough, Massachusetts-based Hologic, Inc. (HOLX) specializes in developing, ...

Hologic Inc. has received a warning letter from the Food and Drug Administration regarding its BioZorb product line, even ...

HOLX touched a new yearly low this week, reflecting market reaction to its mixed Q1 fiscal 2025 results. Still, the stock offers strong rebound potential.

Aryna Sabalenka, Naomi Osaka, Zheng Qinwen, Diana Shnaider, Mirra Andreeva and Jessica Pegula all delivered magic winners on ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on HOLX stock, giving a Buy rating on January 13.Stay Ahead of the ...

Hologic (HOLX) closed the most recent trading day at $70.20, moving -0.13% from the previous trading session. This change lagged the S&P 500's daily gain of 0.12%. Meanwhile, the Dow experienced a ...

Hologic Inc (HOLX) stock saw a decline, ending the day at $70.29 which represents a decrease of $-1.41 or -1.97% from the prior close of $71.7. The stock opened at $72.99 and touched a low of $69.46 ...